Subtype
Kidney and Ureter Neoplasm
CI-CAN-00001051Explore in graph →
Non-malignant518 active trials17 approved drugs81 evidence items
- NCIt
- C7514
Loading cancer entity…
Subtype
CI-CAN-00001051Explore in graph →
Clinical trials
2,410 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003968 | Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer | completed | Phase 2 | 35 | National Cancer Institute (NCI)NIH | 1 | Feb 8, 2013 | clinicaltrials |
| NCT00557609 | Phase 2 Study in Patients With MiT Tumors | completed | Phase 2 | 47 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 3 | Feb 8, 2013 |
| clinicaltrials |
| NCT00193258 | Bevacizumab, Erlotinib, and Imatinib in the Treatment of Advanced Renal Cell Carcinoma | completed | Phase 1 / Phase 2 | 94 | SCRI Development Innovations, LLCOTHER | 0 | Jan 31, 2013 | clinicaltrials |
| NCT00032188 | Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney Cancer | completed | Phase 2 | 65 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00096525 | Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 17, 2013 | clinicaltrials |
| NCT00006486 | Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer | completed | Phase 2 | 335 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00006968 | Pentostatin Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Kidney Cancer | completed | Phase 1 / Phase 2 | 4 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 8, 2013 | clinicaltrials |
| NCT00486538 | Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With Sunitinib | completed | Phase 2 | 53 | AbbVie (prior sponsor, Abbott)INDUSTRY | 2 | Jan 4, 2013 | clinicaltrials |
| NCT00328861 | Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer | completed | Phase 2 | 8 | National Cancer Institute (NCI)NIH | 1 | Nov 5, 2012 | clinicaltrials |
| NCT00058318 | S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer | completed | Phase 2 | 43 | SWOG Cancer Research NetworkNETWORK | 0 | Nov 2, 2012 | clinicaltrials |
| NCT00069160 | Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer | completed | Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Oct 12, 2012 | clinicaltrials |
| NCT00787761 | Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer | completed | Phase 2 | 24 | Northside Hospital, Inc.OTHER | 1 | Oct 1, 2012 | clinicaltrials |
| NCT00031564 | Phase II Study of a B7-1 Gene-Modified Autologous Tumor Cell Vaccine and Systemic IL-2 | completed | Phase 2 | 49 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 27, 2012 | clinicaltrials |
| NCT00338884 | Safety And Effectiveness Of Daily Dosing With 37.5 mg Sunitinib Malate In Patients With Advanced Kidney Cancer | completed | Phase 2 | 120 | PfizerINDUSTRY | 6 | Aug 31, 2012 | clinicaltrials |
| NCT00030992 | BMS 247550 to Treat Kidney Cancer | completed | Phase 2 | 102 | National Cancer Institute (NCI)NIH | 1 | Aug 20, 2012 | clinicaltrials |
| NCT01158534 | Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone Surgery | completed | Phase 2 | 17 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 7, 2012 | clinicaltrials |
| NCT00282048 | Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer | completed | Phase 2 | 62 | PfizerINDUSTRY | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00088374 | 17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease | completed | Phase 2 | 9 | National Cancer Institute (NCI)NIH | 1 | Jul 27, 2012 | clinicaltrials |
| NCT00523159 | IMA901 in Advanced Renal Cell Carcinoma Patients With Measurable Disease(IMA901-202) | completed | Phase 2 | 68 | Immatics Biotechnologies GmbHINDUSTRY | 10 | Jul 10, 2012 | clinicaltrials |
| NCT00076011 | Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma | completed | Phase 2 | 52 | PfizerINDUSTRY | 3 | Jun 26, 2012 | clinicaltrials |
| NCT00035243 | EPO906 Therapy in Patients With Advanced Kidney Cancer | completed | Phase 2 | 53 | Novartis PharmaceuticalsINDUSTRY | 2 | Apr 17, 2012 | clinicaltrials |
| NCT00057889 | Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer | completed | Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00316901 | Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial | completed | Phase 2 | 70 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT01426126 | Study of Genexol-PM in Patients With Advanced Urothelial Cancer Previously Treated With Gemcitabine and Platinum | completed | Phase 2 | 37 | Asan Medical CenterOTHER | 1 | Dec 7, 2011 | clinicaltrials |
| NCT00003887 | Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Nov 30, 2011 | clinicaltrials |
| NCT00197860 | Dendritic Cell Based Therapy of Renal Cell Carcinoma | completed | Phase 1 / Phase 2 | 40 | Inge Marie SvaneOTHER | 1 | Nov 23, 2011 | clinicaltrials |
| NCT00006384 | SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer | completed | Phase 2 | — | City of Hope Medical CenterOTHER | 1 | Oct 20, 2011 | clinicaltrials |
| NCT00036036 | Study of CP-461 in Patients With Advanced Renal Cell Cancer | completed | Phase 2 | 14 | Astellas Pharma IncINDUSTRY | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00267748 | Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC) | completed | Phase 2 | 317 | PfizerINDUSTRY | 1 | Sep 5, 2011 | clinicaltrials |
| NCT00113529 | Study Of SU011248 Plus Gefitinib (Iressa) In Patients With Advanced Renal Cell Carcinoma | completed | Phase 1 / Phase 2 | 42 | PfizerINDUSTRY | 1 | Aug 29, 2011 | clinicaltrials |
| NCT00444314 | Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell Carcinoma | completed | Phase 2 | 82 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Aug 4, 2011 | clinicaltrials |
| NCT00003091 | High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma | completed | Phase 2 | 40 | Hoag Memorial Hospital PresbyterianOTHER | 1 | May 12, 2011 | clinicaltrials |
| NCT00002733 | Biological Therapy in Treating Patients With Metastatic Cancer | completed | Phase 2 | 30 | Hoag Memorial Hospital PresbyterianOTHER | 1 | May 11, 2011 | clinicaltrials |
| NCT00003914 | Dolastatin 10 in Treating Patients With Advanced Kidney Cancer | completed | Phase 2 | 30 | Mayo ClinicOTHER | 1 | May 11, 2011 | clinicaltrials |
| NCT00278174 | Interferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney Cancer | completed | Phase 2 | 7 | Case Comprehensive Cancer CenterOTHER | 1 | May 4, 2011 | clinicaltrials |
| NCT00661609 | A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer | completed | Phase 2 | 54 | AstraZenecaINDUSTRY | 5 | Jan 12, 2011 | clinicaltrials |
| NCT00077974 | A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma. | completed | Phase 2 | 106 | PfizerINDUSTRY | 1 | Oct 13, 2010 | clinicaltrials |
| NCT01176552 | Granulocyte-macrophage Colony-stimulating Factor, Interferon and Interleukin-2 as Adjuvant Treatment for Renal Cancer | completed | Phase 2 | 35 | Kidney Cancer Research BureauOTHER | 1 | Aug 24, 2010 | clinicaltrials |
| NCT01182142 | Study of Capecitabine in Metastatic Non-clear Cell Renal Cell Carcinoma (RCC) Patients | completed | Phase 2 | 51 | Kidney Cancer Research BureauOTHER | 1 | Aug 24, 2010 | clinicaltrials |
| NCT00003928 | Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer | completed | Phase 2 | 32 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00006255 | Magnetic Resonance Imaging-guided Thermal Radiofrequencey Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and Metastases | completed | Phase 2 | 17 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00848640 | Study of Sorafenib in Patients With Advanced Renal Cell Carcinoma(MERITS) | completed | Phase 2 | 75 | Egyptian Foundation For Cancer ResearchOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT00118326 | Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease | completed | Phase 1 / Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | May 14, 2010 | clinicaltrials |
| NCT00004157 | Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 2, 2010 | clinicaltrials |
| NCT00010283 | Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon | completed | Phase 1 / Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 2, 2010 | clinicaltrials |
| NCT00101608 | Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium | completed | Phase 2 | 150 | Bristol-Myers SquibbINDUSTRY | 15 | Mar 2, 2010 | clinicaltrials |
| NCT00254540 | Study of SU011248 in Patients With Advanced Kidney Cancer | completed | Phase 2 | 51 | PfizerINDUSTRY | 1 | Feb 23, 2010 | clinicaltrials |
| NCT00089648 | SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma | completed | Phase 2 | 61 | PfizerINDUSTRY | 1 | Jan 12, 2010 | clinicaltrials |
| NCT00017329 | PS-341 in Treating Patients With Metastatic Kidney Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT00077688 | TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Urothelium | completed | Phase 2 | 44 | Achieve Life SciencesINDUSTRY | 1 | Jun 4, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Feb 8, 2013source: clinicaltrials